Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-11

Clinical Trial Update: A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin [NA]

View source ↗

Summary

This update confirms the completion of a clinical trial evaluating the combination of liquid nitrogen and cantharidin for treating Verruca Vulgaris (common wart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cantharidin (cantharidin)
  • Liquid nitrogen (liquid nitrogen)

Snippet

Sponsor: North Idaho Dermatology | Conditions: Verruca Vulgaris | NA | Status: COMPLETED